According to the Legislative Budget Board (LBB), SB 1232 will have no significant fiscal implications on the state. Any administrative costs incurred by affected agencies, such as the Health and Human Services Commission (HHSC), are expected to be absorbed using existing resources, avoiding the need for additional appropriations.

Although the bill authorizes administrative penalties (up to $1,000 per violation) for noncompliance with its provisions, the Comptroller of Public Accounts notes that the number of violations—and thus the amount of revenue generated from penalties—is unknown. As a result, the fiscal impact from administrative penalties cannot be reliably estimated, introducing uncertainty about any potential revenue offset that might result from enforcement activity.

Additionally, no significant fiscal impact is expected for local governments. The bill does not impose new mandates or costs on local jurisdictions, as it primarily targets state-regulated health care billing practices and oversight mechanisms. Overall, the fiscal implications are considered minimal and manageable within the current administrative and budgetary framework.

SB 1232 is a targeted transparency and consumer protection bill aimed at reducing surprise health care costs related to “facility fees.” These fees are often charged when patients receive care in hospital-affiliated outpatient clinics, even if the service is routine and non-emergency. The bill prohibits facility fees for telehealth and telemedicine services and requires that patients be given written notice at least 10 days in advance when a facility fee will apply to an upcoming service, with limited exceptions for short-notice care. It also requires providers to submit accurate claims using place-of-service codes to ensure insurers can process payments correctly.

The bill represents a thoughtful response to a growing problem in health care billing. As hospital systems acquire more physician practices, patients are increasingly encountering billing practices that obscure true costs and inflate charges for routine care. CSSB 1232 strengthens the principle that patients have the right to know what they will be charged and why, and that insurers should have a clear picture of what services were provided and in what setting. These transparency measures help promote personal responsibility, support consumer choice, and enable fair competition in the health care market.

The bill does, however, increase the regulatory footprint of state agencies. It grants rulemaking and enforcement authority to the Health and Human Services Commission (HHSC) and other applicable agencies, and authorizes administrative penalties of up to $1,000 per violation. While enforcement is necessary to ensure compliance, the penalty structure raises legitimate concerns, especially for smaller health care providers and clinics that may unintentionally violate the law through administrative oversight or misunderstanding of complex billing regulations. A flat fine structure does not distinguish between bad-faith actors and those acting in good faith but who fall short on compliance.

For this reason, an amendment is warranted to align the enforcement mechanism with the bill’s otherwise measured and reasonable scope. A tiered penalty structure, where first-time, technical, or low-impact violations result in a warning or corrective action plan, and escalating penalties apply only for repeated or willful violations, would create a fairer compliance environment. Additionally, HHSC and other regulatory bodies could be required to offer clear guidance, training materials, or implementation checklists for providers before penalties are enforced. These amendments would preserve the bill’s patient protection goals while reducing the risk of regulatory overreach or disproportionate punishment.

Importantly, the bill does not impose a significant cost burden on taxpayers. The Legislative Budget Board found no significant fiscal impact to the state or to local governments, and state agencies are expected to absorb implementation costs with existing resources. While administrative penalties may result in some revenue, the number of violations is uncertain and not expected to meaningfully affect state finances. The optional study on facility fees by the University of Texas Health Science Center at Houston is contingent on future appropriations and would not proceed unless funded by the legislature.

In summary, SB 1232 addresses a real and increasingly problematic aspect of health care billing in a way that enhances transparency and patient protection. However, the enforcement mechanism needs refinement to ensure it does not impose undue penalties on compliant or well-intentioned providers. For these reasons, Texas Policy Research recommends that lawmakers vote YES on SB 1232 and also consider amendments focused on making the penalty structure proportionate, fair, and implementation-friendly.

• Individual Liberty: The bill advances individual liberty by empowering patients with clearer, more accessible information about the costs they may incur when receiving health care services. By requiring providers to give written notice of facility fees, especially in outpatient settings, it ensures individuals can make informed decisions before incurring charges. Prohibiting facility fees for telehealth and telemedicine services also protects patients from being charged for overhead they never physically used. In short, the bill helps preserve patients’ freedom of choice in health care by improving price transparency and reducing billing ambiguity.
• Personal Responsibility: Transparency promotes personal responsibility by equipping patients with the information needed to plan for the financial consequences of their care. When patients are clearly notified in advance of potential facility fees, they are better able to ask questions, compare providers, or decide whether to proceed with a service. This helps shift the system away from surprise billing and toward one where consumers can take greater ownership of their financial and medical decisions.
• Free Enterprise: While the bill does not ban facility fees outright (except in telehealth), it imposes new compliance requirements and limits how and when fees may be charged. These mandates, such as written notifications, billing code accuracy, and advance notice to third-party payers, create additional regulatory hurdles for health care businesses. Some may see this as a necessary check on anti-competitive behavior (e.g., hospital systems leveraging vertical integration to inflate prices), while others may view it as a restriction on how businesses structure and recover costs. The bill supports market fairness but also adds rigidity to provider operations that could inhibit flexibility and innovation without amendment.
• Private Property Rights: The bill does not directly impact private property rights in the traditional sense (e.g., land use, eminent domain, or physical property). However, by regulating billing practices and imposing notice requirements, it does constrain how businesses (especially private, hospital-affiliated facilities) may monetize their services. These constraints are narrowly tailored and focused on transparency rather than outright restriction, so while they regulate the use of private business systems, they do not significantly infringe upon core property rights.
• Limited Government: The bill grants rulemaking and enforcement authority to multiple state regulatory agencies, including the Health and Human Services Commission (HHSC) and other authorities with jurisdiction over health care providers. It authorizes administrative penalties of up to $1,000 per violation, without a tiered or discretionary structure to distinguish between major and minor infractions. This expands the scope of state government and introduces new compliance burdens, which may be at odds with the principle of limited government. These concerns could be mitigated by amending the bill to ensure proportionate enforcement, limit agency discretion through clearer statutory guidance, and incorporate safeguards against regulatory overreach.

• HB 2556 (Same As)